Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers
Condition:   Stem Cell Transplant
Intervention:   Drug: Stem Cell Product
Sponsor:   Assiut University
Not yet recruiting - verified August 2017

Mon, 21 Aug 2017 12:00:00 EDT


Feasibility of Outpatient Closed Loop Control With the Bionic Pancreas in Cystic Fibrosis Related Diabetes
Condition:   Cystic Fibrosis-related Diabetes
Interventions:   Device: Bionic Pancreas;   Other: Usual Care
Sponsors:   Massachusetts General Hospital;   Boston University
Not yet recruiting - verified August 2017

Mon, 21 Aug 2017 12:00:00 EDT


Fish, Polyunsaturated Fatty Acids Intake and Type 2 Diabetes
Condition:   Type2 Diabetes
Intervention:  
Sponsors:   Zhejiang University;   National Institute of Health and Nutrition
Completed - verified July 2017

Mon, 21 Aug 2017 12:00:00 EDT


Diabetes Prevention With Lifestyle Intervention and Metformin Escalation
Condition:   Diabetes
Interventions:   Drug: Metformin Escalation;   Behavioral: Lifestyle Intervention
Sponsor:   Yale University
Not yet recruiting - verified August 2017

Sun, 20 Aug 2017 12:00:00 EDT


Easy Diabetes Treatment Study 1
Condition:   Type 2 Diabetes Mellitus
Interventions:   Device: Standard of Care with EASY DSS;   Other: Standard of Care without EASY DSS
Sponsors:   Läkarexpressen AB;   Region Skane;   Lund University
Recruiting - verified August 2017

Sun, 20 Aug 2017 12:00:00 EDT


Vitamin D in Diabetic Children
Condition:   Vitamin D Deficiency
Intervention:   Diagnostic Test: blood sample test
Sponsor:   Assiut University
Recruiting - verified August 2017

Sun, 20 Aug 2017 12:00:00 EDT


Islet Allotransplantation for Type 1 Diabetic Patients
Condition:   Type 1 Diabetic
Intervention:   Procedure: Allogeneic transplantation of intrahepatic islet
Sponsor:   Second Affiliated Hospital of Guangzhou Medical University
Recruiting - verified August 2017

Sat, 19 Aug 2017 12:00:00 EDT


FreeStyle Libre Flash Accuracy Study
Condition:   Diabetes Mellitus
Intervention:   Device: FreeStyle Libre Flash Glucose Monitoring System
Sponsor:   Abbott Diabetes Care
Not yet recruiting - verified August 2017

Fri, 18 Aug 2017 12:00:00 EDT


The Association Between Diabetes Mellitus, Oral Lichen Planus and Insulin-like Growth Factors 1 and 2 (IGF1 and IGF2)
Conditions:   Oral Lichen Planus;   Diabetes Mellitus
Intervention:   Genetic: comparative semiquantitative immunohistochemistry
Sponsor:   University of Zagreb
Completed - verified August 2017

Fri, 18 Aug 2017 12:00:00 EDT


Effect of Viscous Soluble Fibres on Body Weight
Conditions:   Overweight and Obesity;   T2DM (Type 2 Diabetes Mellitus);   General Population
Intervention:   Dietary Supplement: Viscous Fibre
Sponsor:   St. Michael's Hospital, Toronto
Active, not recruiting - verified August 2017

Thu, 17 Aug 2017 12:00:00 EDT


Effects of Enriched Fruit Juice on Blood Glucose Levels After a Meal in Healthy Subjects
Conditions:   Hyperglycemia, Postprandial;   Healthy
Interventions:   Dietary Supplement: Enriched pomegranate juice;   Dietary Supplement: Placebo beverage
Sponsor:   University of Leeds
Recruiting - verified August 2017

Thu, 17 Aug 2017 12:00:00 EDT


Feasibility and Implementation of a Healthy Lifestyles Program
Conditions:   Health Behavior;   Quality of Life;   Chronic Disease;   Health Promotion;   Stress;   Mental Health Wellness 1
Interventions:   Behavioral: Health and wellness learning sessions;   Behavioral: Brainstorming group sessions;   Behavioral: Individual sessions with a multidisciplinary health team;   Behavioral: Health goal development;   Behavioral: Physical activity and nutrition journals
Sponsor:   McMaster University
Not yet recruiting - verified August 2017

Thu, 17 Aug 2017 12:00:00 EDT


Focused Ultrasound Treatment of Stump Neuromas for the Relief of Chronic Post-Amputation Neuropathic Pain
Conditions:   Phantom Limb Pain;   Residual Limbs;   Amputation
Intervention:   Device: Magnetic resonance-guided focused ultrasound
Sponsor:   Rambam Health Care Campus
Active, not recruiting - verified August 2017

Thu, 17 Aug 2017 12:00:00 EDT


Copeptin and NAFLD
Condition:   NAFLD
Intervention:   Behavioral: Recommended Daily Water Intake
Sponsor:   University of Colorado, Denver
Not yet recruiting - verified August 2017

Wed, 16 Aug 2017 12:00:00 EDT


Cue-Reward Learning and Weight Gain in Youth
Conditions:   Overweight;   Obesity
Intervention:   Other: Functional MRI
Sponsors:   University of California, San Diego;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Institutes of Health (NIH)
Recruiting - verified August 2017

Wed, 16 Aug 2017 12:00:00 EDT
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is carefully evaluating prescription opioid medications approved to treat cough in children
There’s perhaps no more important mandate that we have at the FDA than safeguarding the health and safety of children. For that reason, I believe it’s important that parents and health care providers have the best information available to inform the decisions they make about a child’s health. There are few more common decisions that parents and providers are asked to make than the question of how to appropriately treat a child’s cough and cold symptoms. Sometimes symptoms can be severe enough that prescription medication is needed, but some of these medications pose their own risks – especially for younger children – because they may contain opioids. Other times medication might not be necessary at all.

Mon, 21 Aug 2017 09:31:00 -0400


FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection
As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid in the regulatory evaluation of serological tests to detect recent Zika virus infection.

Thu, 17 Aug 2017 15:52:00 -0400


FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia
The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Thu, 17 Aug 2017 13:22:00 -0400


FDA warns of potential contamination in multiple brands of drugs, dietary supplements
The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.

Fri, 11 Aug 2017 15:34:00 -0400


FDA to expand public education campaign to focus on prevention of youth e-cigarette use
Today, the U.S. Food and Drug Administration announced it would pursue a strategic, new public health education campaign aimed at discouraging the use of e-cigarettes and other electronic nicotine delivery systems (ENDS) by kids. The agency plans to expand its “The Real Cost” public education campaign to include messaging to teens about the dangers of using these products this fall while developing a full-scale campaign to launch in 2018. These efforts are part of the agency’s new comprehensive plan for tobacco and nicotine regulation, as well as ongoing efforts to educate youth about, and protect them from, the dangers associated with using all tobacco products. It is the first time the FDA will be utilizing public health education to specifically target youth use of e-cigarettes or other ENDS.

Tue, 08 Aug 2017 10:00:00 -0400


Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions
U.S. District Judge Robert J. Shelby entered a consent decree of permanent injunction yesterday between the United States and Isomeric Pharmacy Solutions of Salt Lake City, Utah, two of the company’s co-owners, William O. Richardson and Rachael S. Cruz, and chief operating officer Jeffery D. Brown.

Fri, 04 Aug 2017 10:17:00 -0400


FDA approves Mavyret for Hepatitis C
The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis. Mavyret is also approved for adult patients with HCV genotype 1 infection who have been previously treated with a regimen either containing an NS5A inhibitor or an NS3/4A protease inhibitor but not both.

Thu, 03 Aug 2017 15:06:00 -0400


FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia
The U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of chemotherapy drugs daunorubicin and cytarabine.

Thu, 03 Aug 2017 09:09:00 -0400


FDA approves treatment for chronic graft versus host disease
The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more treatments. This is the first FDA-approved therapy for the treatment of cGVHD.

Wed, 02 Aug 2017 11:30:00 -0400


FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia
The U.S. Food and Drug Administration today approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. The drug is approved for use with a companion diagnostic, the RealTime IDH2 Assay, which is used to detect specific mutations in the IDH2 gene in patients with AML.

Tue, 01 Aug 2017 11:10:00 -0400
Diabetes news from the American Diabetes Association

Latest Top (5) News